137 related articles for article (PubMed ID: 7461027)
21. Phenytoin and phenobarbital protein binding alterations in a uremic burn patient.
Pugh CB
Drug Intell Clin Pharm; 1987 Mar; 21(3):264-7. PubMed ID: 3569025
[TBL] [Abstract][Full Text] [Related]
22. Maprotiline: a review of its pharmacological properties and therapeutic efficacy in mental depressive states.
Pinder RM; Brogden RN; Speight TM; Avery GS
Drugs; 1977 May; 13(5):321-52. PubMed ID: 326531
[No Abstract] [Full Text] [Related]
23. Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects.
Perucca E; Hebdige S; Frigo GM; Gatti G; Lecchini S; Crema A
Clin Pharmacol Ther; 1980 Dec; 28(6):779-89. PubMed ID: 6777108
[TBL] [Abstract][Full Text] [Related]
24. Effect of temperature on serum protein binding characteristics of phenytoin in monotherapy paediatric patients with epilepsy.
Kodama H; Kodama Y; Itokazu N; Shinozawa S; Kanemaru R; Sugimoto T
J Clin Pharm Ther; 2001 Jun; 26(3):175-9. PubMed ID: 11422600
[TBL] [Abstract][Full Text] [Related]
25. Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults.
Yacobi A; Lampman T; Levy G
Clin Pharmacol Ther; 1977 Mar; 21(3):283-6. PubMed ID: 837646
[TBL] [Abstract][Full Text] [Related]
26. In vitro protein binding of propafenone in normal and uraemic human sera.
Chan GL; Axelson JE; Price JD; McErlane KM; Kerr CR
Eur J Clin Pharmacol; 1989; 36(5):495-9. PubMed ID: 2753068
[TBL] [Abstract][Full Text] [Related]
27. Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseases.
Tiula E; Haapanen EJ; Neuvonen PJ
Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):469-75. PubMed ID: 3679617
[TBL] [Abstract][Full Text] [Related]
28. Interpatient and intrapatient variability in phenytoin protein binding.
Banh HL; Burton ME; Sperling MR
Ther Drug Monit; 2002 Jun; 24(3):379-85. PubMed ID: 12021629
[TBL] [Abstract][Full Text] [Related]
29. Plasma-protein binding of tricyclic antidepressants.
Braithwaite RA
Postgrad Med J; 1980; 56 Suppl 1():107-11. PubMed ID: 6994085
[TBL] [Abstract][Full Text] [Related]
30. Should we routinely measure free plasma phenytoin concentration?
Rimmer EM; Buss DC; Routledge PA; Richens A
Br J Clin Pharmacol; 1984 Jan; 17(1):99-102. PubMed ID: 6419764
[TBL] [Abstract][Full Text] [Related]
31. Seizures due to maprotiline overdose.
Northup L; Reed G; McAnalley B; Anderson RJ
Ann Emerg Med; 1984 Jun; 13(6):468-70. PubMed ID: 6428280
[TBL] [Abstract][Full Text] [Related]
32. The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment.
Viani A; Rizzo G; Carrai M; Pacifici GM
Br J Clin Pharmacol; 1992 Mar; 33(3):299-304. PubMed ID: 1576051
[TBL] [Abstract][Full Text] [Related]
33. Determination of the antidepressants maprotiline and amoxapine, and their metabolites, in plasma by liquid chromatography.
Wong SH; Waugh SW
Clin Chem; 1983 Feb; 29(2):314-8. PubMed ID: 6821936
[TBL] [Abstract][Full Text] [Related]
34. Effect of propranolol on maprotiline clearance.
Tollefson G; Lesar T
Am J Psychiatry; 1984 Jan; 141(1):148-9. PubMed ID: 6691445
[No Abstract] [Full Text] [Related]
35. Plasma protein binding of maprotiline in geriatric patients--influence of alpha1-acid glycoprotein [proceedings].
Braithwaite RA; Heard R; Snape A
Br J Clin Pharmacol; 1978 Nov; 6(5):448P-449P. PubMed ID: 728299
[No Abstract] [Full Text] [Related]
36. Influence of smoking on serum protein composition and the protein binding of drugs.
Benedek IH; Blouin RA; McNamara PJ
J Pharm Pharmacol; 1984 Mar; 36(3):214-6. PubMed ID: 6144765
[TBL] [Abstract][Full Text] [Related]
37. Influence of first and long-term dialysis on uraemia-associated increased basal production of interleukin-1 and tumour necrosis factor alpha by circulating monocytes.
Herbelin A; Ureña P; Nguyen AT; Zingraff J; Descamps-Latscha B
Nephrol Dial Transplant; 1991; 6(5):349-57. PubMed ID: 1870752
[TBL] [Abstract][Full Text] [Related]
38. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
[TBL] [Abstract][Full Text] [Related]
39. Evidence-based implementation of free phenytoin therapeutic drug monitoring.
Burt M; Anderson DC; Kloss J; Apple FS
Clin Chem; 2000 Aug; 46(8 Pt 1):1132-5. PubMed ID: 10926893
[TBL] [Abstract][Full Text] [Related]
40. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
Lai CM; Moore P; Quon CY
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
